| Chalmer Luke Morris, DO | |
|
2963 E Copper Point Dr, Suite 150, Meridian, ID 83642-9055 | |
| (208) 322-1730 | |
| (208) 322-1731 |
| Full Name | Chalmer Luke Morris |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 2963 E Copper Point Dr, Meridian, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467679464 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
| Saint Alphonsus Medical Center - Nampa | Nampa, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America Llc | 6608056171 | 575 |
| Cep America Llc | 6608056171 | 575 |
News Archive
Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.
A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.
Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership with LightArray Biotech Company, Ltd., to provide Aushon's comprehensive suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
› Verified 1 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811357023 PECOS PAC ID: 6608056171 Enrollment ID: O20160803003292 |
News Archive
Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.
A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.
Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership with LightArray Biotech Company, Ltd., to provide Aushon's comprehensive suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chalmer Luke Morris, DO 2963 E Copper Point Dr, Suite 150, Meridian, ID 83642-9055 Ph: (208) 322-1730 | Chalmer Luke Morris, DO 2963 E Copper Point Dr, Suite 150, Meridian, ID 83642-9055 Ph: (208) 322-1730 |
News Archive
Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.
A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.
Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership with LightArray Biotech Company, Ltd., to provide Aushon's comprehensive suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
› Verified 1 days ago
Dr. Mark C Thomas, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2963 E Copper Point Dr, Suite 150, Meridian, ID 83642 Phone: 208-322-1730 Fax: 208-322-1731 | |
Dr. Andrew Garry Southard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2963 E Copper Point Dr, Suite 150, Meridian, ID 83642 Phone: 208-322-1730 Fax: 208-322-1731 | |
Terisa Joann Zimmerman, MS, LAT, ATC Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2000 S Millenium Way, Meridian, ID 83642 Phone: 208-871-8359 | |
Travis W Robbins, NP Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1900 W Chinden Blvd, Meridian, ID 83646 Phone: 208-809-2860 Fax: 208-809-2861 | |
Dr. Brian Craig Kitamura, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2963 E Copper Point Dr, Meridian, ID 83642 Phone: 208-322-1730 | |
Todd Robert Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3835 S Firenze Way, Meridian, ID 83642 Phone: 801-699-3892 | |
Dr. Michael A Watts, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2963 E Copper Point Dr, Meridian, ID 83642 Phone: 208-322-1730 Fax: 208-322-1731 |